Back to search

Article

External validation of the VIGex gene-expression signature as a novel predictive biomarker for immune checkpoint treatment

2023-07-21

Abstract excerpt

<title>Abstract</title> <p>Immune gene expression signatures are emerging as potential biomarkers for immunotherapy. Yet, their limited predictive performance and complexity limit routine clinical implementation. VIGex is a 12-gene expression classifier developed in both nCounter (Nanostring) and RNA-Seq assays and analytically validated across laboratories. VIGex classifies tumor samples into Hot, Intermediate-C...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c9b7a1d8-0e14-53ef-af59-5e7262f7ab22
DOI
10.21203/rs.3.rs-3153100/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
External validation of the VIGex gene-expression signature as a novel predictive biomarker for immune checkpoint treatmentDOI 10.21203/rs.3.rs-3153100/v1
Development and Performance of a CD8 Gene Signature for Characterizing Inflammation in the Tumor Microenvironment across Multiple Tumor TypesSemantic proximity
Association of differential expression of immunoregulatory molecules and presence of targetable mutations may inform rational design of clinical trials.Semantic proximity
Tumor Immune Cell Infiltration Patterns and Predictable Clinical Benefit with Nivolumab in Combination with Ipilimumab for 3P ImplementationSemantic proximity
Immune cell landscape reveals 5 immune-related subtypes and molecular characteristics with prognostic and therapeutic implications in pan-cancer.Semantic proximity
A transcriptome-wide meta-analysis reveals lack of cancer-cell intrinsic determinants of response to immune checkpoint blockadeSemantic proximity
Upfront whole blood transcriptional patterns in patients receiving immune checkpoint inhibitors associate with clinical outcomeSemantic proximity
Identification and Utilization of Biomarkers to Predict Response to Immune Checkpoint Inhibitors.Semantic proximity
Development and validation of the Immune Profile Score (IPS), a novel multi-omic algorithmic assay for stratifying outcomes in a real-world cohort of advanced solid cancer patients treated with immune checkpoint inhibitorsSemantic proximity
A Clinically Translatable Immune-based Classification of HPV-associated Head and Neck Cancer with Implications for Biomarker-Driven Treatment Deintensification and ImmunotherapySemantic proximity
Development and validation of blood-based predictive biomarkers for response to PD-(L)-1 checkpoint inhibitors: evidence of a universal systemic core of 3D immunogenetic profiling across multiple oncological indicationsSemantic proximity
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapySemantic proximity
Prediction of immune checkpoint inhibition with immune oncology-related gene expression in gastrointestinal cancer using a machine learning classifierSemantic proximity
Select a neighboring publication to make it the new centre.